Forum for Applied Imaging Research (FAIR): Homegrown Radiopharmaceuticals & Translation to Humans
Date
Type
Time Duration
Location
Speakers
Chief, Molecular Imaging and Therapeutics Clinical Section
University of California, San Francisco
MODERATOR
Dr. Robert Flavell received his medical degree from Weill Cornell Medical College, and his PhD from the Rockefeller University as part of the Tri-Institutional MD PhD program. He completed his one-year internship at the Memorial SloanKettering Cancer Center in New York. Dr. Flavell completed his radiology residency at UCSF, including an NIH T32 funded research fellowship, and subsequently completed a one-year fellowship in nuclear medicine. In June 2016. he joined the faculty as an Assistant Professor in Residence. Dr. Flavell’s laboratory, the Molecular Imaging Lab, focuses on the development of new molecular imaging tools for a better understanding of disease progression in patients with prostate and other cancers.
University of California, San Francisco
11C-YJH08, 18F-TRX, 64Cu-GRIP B
Dr. Michael Evans is a chemical biologist with an interest in biomarker discovery with proteomics, nuclear medicine, theranostics, and molecular imaging. Dr. Evans earned a BA in Chemistry from St. Mary’s College of Maryland and he obtained his PhD in Organic Chemistry from The Scripps Research Institute (CA) under the supervision of Professor Benjamin Cravatt. This was followed by a postdoctoral fellowship in Molecular Imaging from the Memorial Sloan Kettering Cancer Center in New York under the supervision of Professors Charles Sawyers and Jason Lewis. In 2013, Dr. Evans accepted a faculty position at UCSF.
Director, Radiopharmaceutical Research Program, Center for Molecular and Functional Imaging (CMFI)
Joint Faculty Scientist, Lawrence Berkeley National Laboratory
University of California, San Francisco
RP-115 EAAT2 TRACER FOR ALS/TBI/AD
Dr. Henry VanBrocklin obtained his PhD in Radiopharmaceutical Chemistry from Washington University, St. Louis in 1990, and he completed a two-year postdoctoral program at the University of Illinois, Urbana in 1992. He maintains an active radiotracer research program in addition to providing tracers for collaborative basic science and translational clinical research. His research interests include short-lived radioisotope production to the creation of fluorine-18 and carbon-11 labeling chemistry strategies for new radiotracer preparations and applications. Dr. VanBrocklin is one of the core faculty for the Master's in Biomedical Imaging (MSBI) program and a member of the MSBI executive committee.
University of California, San Francisco
INFECTION RADIOTRACER(S)
Dr. David Wilson received his BS degree from Harvard University in Biochemistry, and completed his MD/PhD training at Columbia University in New York City. His PhD mentor was Dr. Ronald Breslow, a pioneer in artificial enzymes, the hydrophobic effect, and bio-organic chemistry. Dr. Wilson’s subsequent clinical training was in radiology and neuroradiology at the University of California, San Francisco (UCSF), where he trained further in the laboratory of Professor John Kurhanewicz and subsequently became a faculty member in 2010. He has since established a basic science laboratory investigating the detection and characterization of cancer via analyte sensing, and developing probes for positron emission tomography (PET) and hyperpolarized 13C spectroscopy. His laboratory has most recently studied imaging infection using bacteria-specific metabolic pathways, and ways to detect ACE2 suppression in SARS-CoV-2.